Found 16 articles for: "Keratosis"
Halo Seborrheic Keratosis in a Patient of Color With Vitiligo
January 2026 | Volume 25 | Issue 1 | Case Reports | 95 | Copyright © January 2026
A 73-year-old woman with Fitzpatrick skin type V presented with a long-standing brownish-black, three-tone macule on the right anterior thigh that developed a sharply demarcated depigmented halo....
Read MoreSynergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses
May 2025 | Volume 24 | Issue 5 | Editorials | e35 | Copyright © May 2025
Citation: Regester RM, Cannella AC, Thiele GM, et al. Synergistic mechanisms of 5-fluorouracil and imiquimod in the treatment of actinic keratoses. J Drugs Dermatol. 2025;24(5):e35....
Read MoreAntioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses
February 2025 | Volume 24 | Issue 2 | Original Article | 183 | Copyright © February 2025
Background: Seborrheic keratoses (SKs) are the most common skin lesions to prompt visits to a dermatologist. Patients may be concerned about unsightly appearance, irritation, or ...
Read MorePatient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK)
May 2024 | Volume 23 | Issue 5 | Original Article | 338 | Copyright © May 2024
Read MoreEvaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris
January 2024 | Volume 23 | Issue 1 | Original Article | 1274 | Copyright © January 2024
Background: Keratosis pilaris (KP) is a benign dermatosis consisting of folliculocentric keratotic papules or pustules with surrounding erythema, often on proximal extensor surfaces of extremitie...
Read MoreEfficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis
December 2023 | Volume 22 | Issue 12 | Original Article | 1160 | Copyright © December 2023
Background: Porokeratosis is a group of disorders characterized by aberrant skin keratinization secondary to genetic alterations in the mevalonate pathway, which participates in ...
Read MoreKeratosis Pilaris: Treatment Practices of Board-Certified Dermatologists
October 2023 | Volume 22 | Issue 10 | Original Article | 985 | Copyright © October 2023
Keratosis pilaris (KP) is a chronic disorder of follicular hyperkeratinization and perifollicular erythema with lesions affecting the extensor surfaces of arms, upper legs, and buttocks. While there i...
Read MoreA Review of the Efficacy of Topical Statins for Treating Disseminated Superficial Actinic Porokeratosis
October 2023 | Volume 22 | Issue 10 | Original Article | 1053 | Copyright © October 2023
Porokeratosis is a rare group of acquired or hereditary dermatoses characterized by linear or annular plaques with a keratotic border. DSAP is the most common porokeratosis, and lesions range fro...
Read MoreNon-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma
May 2023 | Volume 22 | Issue 5 | Original Article | 440 | Copyright © May 2023
Importance: Actinic keratosis (AK) is a premalignant lesion that has a1% to 10% potential of progression to squamous cell carcinoma (SCC), but it is not possible to determine whi...
Read MoreShining Light on PDT and Actinic Keratosis
February 2023 | Volume 22 | Issue 2 | Features | 226 | Copyright © February 2023
Photodynamic therapy (PDT) is a non-invasive treatment modality involving photosensitizers that are activated by absorption of visible light to initially form the excited singlet state, followed by tr...
Read MoreClassifying Actinic Keratosis: What the Reality of Everyday Clinical Practice Shows Us
August 2022 | Volume 21 | Issue 8 | Original Article | 845 | Copyright © August 2022
Difficulties faced by clinicians in routine clinical practice when selecting the appropriate treatment for patients with actinic keratosis (AK) include: the independent evaluation of AK lesions, the a...
Read MoreDermoscopy and Reflectance Confocal Microscopy in Actinic Keratosis, Intraepithelial Carcinoma, and Invasive Squamous Cell Carcinoma
March 2022 | Volume 21 | Issue 3 | Original Article | 259 | Copyright © March 2022
Background: Patients with multiple actinic keratosis (AK), have pre-neosplastic abnormalities, constituting the sites of new tumors, this region is called the cancerization field. Due...
Read More2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and Care
February 2022 | Volume 21 | Issue 2 | Original Article | 128 | Copyright © February 2022
This is a report of the survey results from the International Dermatology Outcome Measures (IDEOM) actinic keratosis (AK) workgroup. The purpose of the survey was to compile a list of gaps within AK c...
Read MoreAdvances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report
August 2021 | Volume 20 | Issue 8 | Original Article | 888 | Copyright © August 2021
Background: Actinic Keratosis (AK) is a potentially pre-malignant tumor with a poorly defined risk of progression to invasive squamous cell carcinoma (SCC). Because of the typical nee...
Read MoreTirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results
November 2020 | Volume 19 | Issue 11 | Original Article | 1093 | Copyright © November 2020
Background: Current field-directed treatments of actinic keratosis (AK), a pre-malignant condit...
Read MoreAdvancing the Understanding of Seborrheic Keratosis
May 2017 | Volume 16 | Issue 5 | Original Article | 419 | Copyright © May 2017
The seborrheic keratosis, which is ubiquitous throughout all populations, is a benign tumor of the skin. Seborrheic keratosis are among the top 20 dermatologic conditions treated by dermatologists....
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
